Biohaven Long Term Debt 2016-2022 | BHVN
Biohaven long term debt from 2016 to 2022. Long term debt can be defined as the sum of all long term debt fields.
Biohaven Annual Long Term Debt
(Millions of US $) |
| 2021 |
$627 |
| 2020 |
$267 |
| 2019 |
$ |
| 2018 |
$ |
| 2017 |
$ |
| 2016 |
$1 |
| 2015 |
$ |
Biohaven Quarterly Long Term Debt
(Millions of US $) |
| 2022-09-30 |
|
| 2022-06-30 |
$765 |
| 2022-03-31 |
$634 |
| 2021-12-31 |
|
| 2021-09-30 |
$619 |
| 2021-06-30 |
$274 |
| 2021-03-31 |
$271 |
| 2020-12-31 |
$267 |
| 2020-09-30 |
$264 |
| 2020-06-30 |
|
| 2020-03-31 |
|
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
|
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-03-31 |
$1 |
| 2016-12-31 |
$1 |
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
|
| 2015-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.240B |
$0.463B |
|
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
|
